Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera vs Reference ESAs in CKD Anemia
NCT00773513Phase 4Completed
- Sponsor
- Roche
- Start
- Dec 2008
- Primary completion
- Jul 2017
- Modality
- Polymer-based Nanoparticles
- Countries
- 27
01
Overview
A Phase 4 trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease (CKD-A), sponsored by Roche. Started Dec 2008; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00773513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773513.